Postdoctoral FellowNational Cancer Institute | National Institutes of Health, United States
36: Phosphoproteomic Mass Spectrometry Reveals A Novel Therapeutic Target in Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Thursday, March 21, 202410:57am – 11:07am ET